000 | 01510 a2200385 4500 | ||
---|---|---|---|
005 | 20250515062937.0 | ||
264 | 0 | _c20070626 | |
008 | 200706s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm0613119 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorrell, Andrew | |
245 | 0 | 0 |
_aInvestigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase I inhibition and cytotoxicity in human cancer cell cultures. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cMay 2007 |
||
300 |
_a2040-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndenes _xchemical synthesis |
650 | 0 | 4 |
_aIsoquinolines _xchemical synthesis |
650 | 0 | 4 |
_aLactams _xchemical synthesis |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aPyridines _xchemistry |
650 | 0 | 4 | _aTopoisomerase I Inhibitors |
700 | 1 | _aPlaczek, Michael S | |
700 | 1 | _aSteffen, Jamin D | |
700 | 1 | _aAntony, Smitha | |
700 | 1 | _aAgama, Keli | |
700 | 1 | _aPommier, Yves | |
700 | 1 | _aCushman, Mark | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 50 _gno. 9 _gp. 2040-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0613119 _zAvailable from publisher's website |
999 |
_c16955090 _d16955090 |